These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21129498)

  • 1. Grants4Targets - an innovative approach to translate ideas from basic research into novel drugs.
    Lessl M; Schoepe S; Sommer A; Schneider M; Asadullah K
    Drug Discov Today; 2011 Apr; 16(7-8):288-92. PubMed ID: 21129498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grants4Targets: an open innovation initiative to foster drug discovery collaborations.
    Dorsch H; Jurock AE; Schoepe S; Lessl M; Asadullah K
    Nat Rev Drug Discov; 2015 Jan; 14(1):74-6. PubMed ID: 25430867
    [No Abstract]   [Full Text] [Related]  

  • 3. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
    Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
    Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medicen Paris Région: A world-class ''competitiveness cluster'' in the Paris region incorporating a neuroscience ''subcluster''].
    Canet E
    Med Sci (Paris); 2007 Apr; 23(4):435-9. PubMed ID: 17433236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Innovative Medicine Initiative (IMI)].
    Bril A; Canet E
    Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating the discovery of new drug targets with chemical proteomics.
    Cheung AK; Jain RK
    IDrugs; 2010 Dec; 13(12):862-8. PubMed ID: 21154144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public-private partnership: from there to here.
    Croft SL
    Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The World Bank's innovation market.
    Wood RC; Hamel G
    Harv Bus Rev; 2002 Nov; 80(11):104-10, 112-3, 134. PubMed ID: 12422794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opening up to precompetitive collaboration.
    Altshuler JS; Balogh E; Barker AD; Eck SL; Friend SH; Ginsburg GS; Herbst RS; Nass SJ; Streeter CM; Wagner JA
    Sci Transl Med; 2010 Oct; 2(52):52cm26. PubMed ID: 20926831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of potential drug targets based on simple sequence properties.
    Li Q; Lai L
    BMC Bioinformatics; 2007 Sep; 8():353. PubMed ID: 17883836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The discovery process in the pharmaceutical industry].
    Scatton B
    J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the right targets in oncology: challenges and alternative approaches.
    Stock JK; Jones NP; Hammonds T; Roffey J; Dillon C
    J Biomol Screen; 2015 Mar; 20(3):305-17. PubMed ID: 25614505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's next in translational medicine?
    Littman BH; Di Mario L; Plebani M; Marincola FM
    Clin Sci (Lond); 2007 Feb; 112(4):217-27. PubMed ID: 17223795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical drug development.
    Brodniewicz T; Grynkiewicz G
    Acta Pol Pharm; 2010; 67(6):578-85. PubMed ID: 21229871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symposium review: drug discovery, development and clinical research in academia.
    Vlaar CP; Hernández L
    P R Health Sci J; 2009 Sep; 28(3):268-73. PubMed ID: 19715120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.